(Q63319966)

English

Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Phase 3 Study of Poly Unsaturated Fatty Acids of Omega 3 as an Anti Platelet Agent on Biomarkers of Cardiac Necrosis Including CKMB and Troponin I and Inflammation Marker CRP (English)

0 references

0 references

0 references

0 references

coronary artery disease

0 references

sponsor

Shahid Beheshti University of Medical Sciences

0 references

start time

January 2012

0 references

end time

May 2012

0 references

number of participants

104

0 references

clinical trial phase

phase III clinical trial

0 references

minimum age

18 year

0 references

maximum age

80 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01521845

0 references

(Q63319966)

Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)